Melikian, Haley
connection in network: https://profiles.umassmed.edu/profile/131975/198
connection weight: 0.12066
has connection details: https://profiles.umassmed.edu/profile/56101019
predicate node: https://profiles.umassmed.edu/profile/198
sort order: 68
object: Protein Domains
predicate: hasResearchArea
subject: Melikian, Haley
type: Connection

Connection Details
type: Class

connection in network
tag name: prns:connectionInNetwork
type: ObjectProperty

connection weight
tag name: prns:connectionWeight
type: DatatypeProperty

end date
tag name: prns:endDate
type: DatatypeProperty

Faculty Rank
type: Class

full name
tag name: prns:fullName
type: DatatypeProperty

has connection details
tag name: prns:hasConnectionDetails
type: ObjectProperty

has faculty rank
tag name: prns:hasFacultyRank
type: ObjectProperty

is primary position
tag name: prns:isPrimaryPosition
type: DatatypeProperty

latitude
tag name: prns:latitude
type: DatatypeProperty

longitude
tag name: prns:longitude
type: DatatypeProperty

photo
tag name: prns:mainImage
type: ObjectProperty

MeSH DescriptorUI
tag name: prns:meshDescriptorUI
type: DatatypeProperty

number of authors
tag name: prns:numberOfAuthors
type: DatatypeProperty

number of publications
tag name: prns:numberOfPublications
type: DatatypeProperty

Person ID
tag name: prns:personId
type: DatatypeProperty

person in primary position
tag name: prns:personInPrimaryPosition
type: ObjectProperty

position in department
tag name: prns:positionInDepartment
type: ObjectProperty

position in division
tag name: prns:positionInDivision
type: ObjectProperty

predicate node
tag name: prns:predicateNode
type: ObjectProperty

sort order
tag name: prns:sortOrder
type: DatatypeProperty

start date
tag name: prns:startDate
type: DatatypeProperty

uniqueness weight
tag name: prns:uniquenessWeight
type: DatatypeProperty

Post Docs
tag name: umass:PostDocs
type: DatatypeProperty

Rotation Projects
tag name: umass:Rotation
type: DatatypeProperty

Department
type: Class

Division
type: Class

HR job title
tag name: vivo:hrJobTitle
type: DatatypeProperty

Position
type: Class

position in organization
tag name: vivo:positionInOrganization
type: ObjectProperty

preferred title
tag name: vivo:preferredTitle
type: DatatypeProperty
type: FunctionalProperty

object
tag name: rdf:object
type: ObjectProperty

predicate
tag name: rdf:predicate
type: ObjectProperty

subject
tag name: rdf:subject
type: ObjectProperty

type
tag name: rdf:type
type: ObjectProperty

label
tag name: rdfs:label
type: DatatypeProperty

Concept
type: Class

Agent
type: Class

first name
tag name: foaf:firstName
type: DatatypeProperty
type: FunctionalProperty

last name
tag name: foaf:lastName
type: DatatypeProperty
type: FunctionalProperty

Organization
type: Class

Person
type: Class

Neurobiology
type: Department
type: Organization

UMass Chan Medical School
type: Organization

Melikian, Haley
first name: Haley
last name: Melikian
full name: Haley E Melikian PhD
has faculty rank: Professor
latitude: 42.27737440000000
longitude: -71.76346650000000
photo: https://profiles.umassmed.edu/profile/Modules/CustomViewPersonGeneralInfo/PhotoHandler.ashx
Person ID: 302
person in primary position: Professor
type: Agent
type: Person
Post Docs: The Melikian Lab seeks a creative and motivated PhD neurobiologist to join our investigative team to study the mechanisms that govern addictive and motivated behaviors, with a focus on circuits that converge on and modulate dopaminergic terminals. We leverage intersectional approaches spanning from molecules to behavior, and utilize mouse genetic, viral, optogenetic and photometric methods. We are seeking postdoctoral applicants with a strong track record of productivity, who will take the lead on a novel project. Applicants will optimally have experience in mouse handling and modern neurobiology approaches (e.g. optogenetics, photometry), but other strong candidates will also be considered. The Neurobiology Department at UMASS Chan Medical School is the hub of a vibrant multidisciplinary neuroscience community, with research strengths in neuropsychiatric disorders, neurodegeneration, neuroinflammation, neuroplasticity, and neurodevelopment. Under the leadership of our recently appointed Chair, Dr. Danny Winder, the department provides an exceptional and interactive training environment that emphasizes team science in a diverse and inclusive space. Interested applicants should submit a CV and names of three references to Dr. Melikian: haley(dot)melikian(at)umassmed(dot)edu.
Rotation Projects: 1. Parkinson's Disease: Signaling Cascades that lead to dopamine neuron degeneration Parkinson's disease (PD) is the 2nd most prevalent neurodegenerative disease and affects >1 million individuals in the U.S., with a 50% higher occurance in males vs. females. Dopamine (DA) is required for movement initiation and PD is the result of DA neuron (DAN) cell death, leading to freezing, gait instability, and resting tremor. Therapy options for PD patients are limited to approaches that replace DA. These are effective in early disease stages, but wane in efficacy as PD progresses. Importantly, none of these treatment strategies target the root cause of PD: DAN cell death. The lack of progress in developing impactful treatments is due, in part, to a lack of understanding the cellular signaling dysfunction that leads to DAN cell death in PD. Moreover, it is completely unknown why males are more susceptible to PD than females. Rit2 (AKA: Ras-like in neurons; Rin) is a small neuronal GTPase that is highly enriched in DANs, and is a PD risk allele. Importantly, a recent single-cell RNA sequencing study from idiopathic PD patients revealed a patient subpopulation in which Rit2 was markedly decreased in DANs. While intriguing, it was yet unknown whether Rit2 losses were simply due to DAN cell death, or actually causative. In collaboration with the UMASS Chan Gene Therapy Center, we recently developed a novel, AAV- and shRNA-mediated approach to silence Rit2 in mouse DANs and found that Rit2 knockdown (Rit2-KD) leads to a significant, striking, and progressive PD phenotype that develops more rapidly in males than females. This new PD mouse model presents a unique opportunity to probe multiple questions regarding Rit2 and PD. What gene expression changes occur downstream of Rit2 loss? Are any of these druggable targets? What are the differences between males and females that make males more susceptible to DAN cell death? Is there an intervention window in which DAN viability can be …
Rotation Projects: 2. Modulatory glutamate signaling: impact on motor function, novelty, and cocaine addiction Glutamate is the major excitatory neurotransmitter in the brain, but also has a modulatory role by signaling through metabotropic glutamate receptors (mGluRs). Recent work from our laboratory revealed that mGluR5 expression in DA neurons is required for DA signaling and several DA-dependent behaviors including motor learning and cocaine reward. However, the circuit- and mechanistic-specific underpinnings of these processes are unkonwn. Using a novel conditional knockout model, we are leveraging genetically encoded DA sensors to determine how DAergic mGluR5 impacts DA neuron function and DA-dependent behaviors in mice. Rotation students will learn to behaviorally assess cocaine addiction in this mouse model, and will learn immunohistochemical approaches to validate viral expression Cocaine Fails to increase DA in mGluR5-DA-silenced mice. Fiber photometry using genetically-encoded DA sensors during cocaine response. Control or mGluR5-DA-silenced mice were injected with 7.5 mg/kg cocaine and DA signals were recorded in the nucleus accumbens using dLight 1.2 sensor. Control mice: Cocaine caused a significant increase in the total DA signal from 3-5 min post-injection as compared to saline-injections. mGluR5-DA-silenced mice: Cocaine failed to significantly increase DA signals. *p<0.05, paired Student's t test, n=4-5.
Rotation Projects: 3. Nociceptin: A neuropeptide that impacts cocaine sensitivity Nociceptin is an endogenous opiate-like neuropeptide that is implicated in pain and reward motivation. Recent studies suggest that nociceptin has the capacity to block cocaine's initial addictive properties, but the mechanisms underlying nociceptin's actions are largely unknown. Work in our lab has discovered that nociceptin blocks cocaine reward, and does so by acting directly on DA axon terminals in the nucleus accumbens, the brain's "reward center". In addition, our results suggest that nociceptin likely shifts cocaine sensitivity, and does so by controlling reward tone differentially in males vs. females. These exciting results may pave the way towards harnesing nociceptin signaling as a potential addiction therapeutic. However, the mechanisms underlying nociceptin's actions are unknown, nor is it known whether nociceptin specificallly impacts cocaine reward, or other drugs of abuse. There are two possible rotation projects: Project 3a: Impact of nociceptin signaling on other drugs of abuse. Students will conduct addiction behavioral assays while infusing nociceptin directly into the nucleus accumbens in mice. Students will learn mouse handling and stereotaxic surgery, and mouse behavioral assays. Project 3b: Sex-specific differences in nociceptin signalig. Students will use RT-qPCR to test whether males and female mouse midbrain neurons express differing amounts of the nociceptin receptor, NOPR. Students will learn mouse handling skills, brain harvesting, and RT-qPCR. Nociceptin infusion into the nucleus accumbens blocks cocaine preference in females. Conditioned Place Preference Assay (CPP). Wildtype female mice received either saline or 10mg/kg cocaine (I.P.) and were trained for 3 days in a 3-chambered CPP aparatus, while being infused with either vehicle or 500nM nociceptin. Preference scores were determined on test days. Control-infused mice exhibited signifiant preference to the cocaine-paired…
Rotation Projects: 4. Dopamine Transporter (DAT) Trafficking in Cocaine Addiction DAT is a membrane protein in dopamine (DA) axon teminals whose primary function is to remove released dopamine and thereby terminate synpatic transmission. Addictive psychostimulants, such as cocaine, block DAT function, which increases extracellular DA and is responsible for cocaine's addictive properties. DAT is not static at the plasma membrane, but is dynamically regulated by membrane traffficking. This project is to determine whether DAT membrane trafficking is required for cocaine addiction. Our lab has developed a novel, AAV-mediated, in vivo molecular replacement strategy, that replaces wildytpe DAT with DAT trafficking dysregulated mutants in adult mice. There are 2 possible rotation projects: Project 1a: Rotation students will assist in behaviorally assessing replacement mice as compared to controls, and will additionally use immumohistochemical approaches to validate mutant protein expression in dopamine neurons in situ. Students will gain experience in mouse behavior, brain dissection, preparation of brain slices, and immunhistochemical techniques in mouse brain. Project 1b: Rotation students will develop a CRISPR/Cas9 guide RNA in order to perform gene editing and mutate DAT in vivo, and will test its efficacy in vitro. Students will learn guide RNA design, and mammalian tissue culture, and genomic sequencing.
preferred title: Professor

Protein Domains
MeSH DescriptorUI: D000072417
number of authors: 101
number of publications: 154
uniqueness weight: 0.924668
type: Concept

https://profiles.umassmed.edu/profile/56101019
end date: 2016-12-16T00:00:00
number of publications: 1
start date: 2016-12-16T00:00:00
type: Connection Details

Professor
sort order: 3
type: Faculty Rank

Professor
is primary position: true
position in department: Neurobiology
position in division: https://profiles.umassmed.edu/profile/15590085
sort order: 1
type: Position
HR job title: Professor
position in organization: UMass Chan Medical School